China revises VB2 injection instruction

On 11 June, the National Medical Products Administration announced a description revision for vitamin B2 (VB2) injections regarding their adverse reactions, contraindications and so on. Accordingly, all domestic VB2 producers should report their desc...

Vitamins China E-News 202006

www.cnchemicals.com